BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11394932)

  • 21. Do glutamatergic agents represent a new class of antidepressant drugs? Part 2.
    Sanacora G
    J Clin Psychiatry; 2009 Nov; 70(11):1604-5. PubMed ID: 20031105
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
    Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors.
    Musazzi L; Treccani G; Mallei A; Popoli M
    Biol Psychiatry; 2013 Jun; 73(12):1180-8. PubMed ID: 23273725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension test.
    Linck VM; Costa-Campos L; Pilz LK; Garcia CR; Elisabetsky E
    Behav Pharmacol; 2012 Apr; 23(2):171-7. PubMed ID: 22327021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biochemistry of depression.
    Gordon AM
    J Int Med Res; 1977; 5 Suppl 4():81-4. PubMed ID: 563350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for AMPA receptors in mood disorders.
    Alt A; Nisenbaum ES; Bleakman D; Witkin JM
    Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of glutamate in the pathophysiology of depression.
    Palucha A; Pilc A
    Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
    Paul IA; Nowak G; Layer RT; Popik P; Skolnick P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):95-102. PubMed ID: 8169857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
    Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
    Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate system as target for development of novel antidepressants.
    Catena-Dell'Osso M; Fagiolini A; Rotella F; Baroni S; Marazziti D
    CNS Spectr; 2013 Aug; 18(4):188-98. PubMed ID: 23369807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacological properties of antidepressants.
    Racagni G; Popoli M
    Int Clin Psychopharmacol; 2010 May; 25(3):117-31. PubMed ID: 20305568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nonselective effect of selective antidepressants.
    Montgomery SA
    Adv Biochem Psychopharmacol; 1982; 32():49-55. PubMed ID: 6178265
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer antidepressants: further reflections.
    Shader RI; Fogelman SM; Greenblatt DJ
    J Clin Psychopharmacol; 1997 Apr; 17(2):75-7. PubMed ID: 10950466
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development.
    Preskorn SH
    Adv Neurobiol; 2023; 30():1-18. PubMed ID: 36928844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtypes of Major Depressive Disorder Based on Pharmacological Responsiveness.
    Preskorn SH
    J Psychiatr Pract; 2021 Nov; 27(6):448-452. PubMed ID: 34768267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bright future of researching AMPA receptor agonists for depression treatment.
    Yang C; Zhou W; Li X; Yang J
    Expert Opin Investig Drugs; 2012 May; 21(5):583-4; author reply 584-5. PubMed ID: 22375566
    [No Abstract]   [Full Text] [Related]  

  • 40. Biogenic amines and emotion.
    Schildkraut JJ; Kety SS
    Science; 1967 Apr; 156(3771):21-37. PubMed ID: 5335690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.